Perioral Dermatitis
Perioral Dermatitis
Perioral Dermatitis
net/publication/5316567
Perioral dermatitis
CITATIONS READS
26 5,673
3 authors, including:
Petra Turcic
University of Zagreb
54 PUBLICATIONS 284 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
The effect of parabens on the development of human breast cancer View project
All content following this page was uploaded by Petra Turcic on 28 April 2019.
Perioral Dermatitis
Suzana Ljubojević1, Jasna Lipozenčić1, Petra Turčić2
1
University Department of Dermatology and Venereology, Zagreb University Hospital
Center and School of Medicine; 2Faculty of Pharmacy and Biochemistry, University of
Zagreb, Zagreb, Croatia
Introduction Epidemiology
Perioral dermatitis (PD), rosacea-like derma- PD predominantly affects women, who ac-
titis, periorificial dermatitis, light-sensitive sebor- count for an estimated 90% of cases. The num-
rheic, chronic papulopustular facial dermatitis, ber of male patients is assumed to be increasing
papulopustular facial dermatitis, granulomatous because of changes in their cosmetic habits. PD
perioral dermatitis, lupus-like perioral dermatitis, may occur but is rarely diagnosed in children (2,
stewardess disease are synonyms for a chronic 3). The vast majority of patients are women aged
papulopustular facial dermatitis. It mostly occurs in 20-45 years (2).
young women. The clinical and histologic features
of the lesions resemble those of rosacea. Patients Pathogenesis
require systemic and/or topical treatment, evalua- There may be more than one cause of PD
tion of the underlying factors, and reassurance. In (Table 1). The etiology of PD remains unknown;
1957, Frumess and Lewis described cyclic derma- however, the uncritical use of topical steroids for
titis affecting the skin of the perioral region, prin- minor skin alterations of the face often precedes
cipally among young females, by the term “light the manifestation of the disease (5). The underly-
sensitive seborrhoeid” (1). ing cause cannot be detected in all patients. Once
96
Ljubojević et al. Acta Dermatovenerol Croat
Perioral dermatitis 2008;16(2):96-100
patients experienced significantly increased tran- allowing the atrophic collagen to recover (9). Oth-
sepidermal water loss compared with rosacea pa- ers taper the dose of topical corticosteroids by re-
tients and a control group, which indicated a skin ducing the frequency of administration (10).
barrier function disorder. This type of testing is not The second factor in treatment is suppression
routinely used (7). of bacterial infection in hair follicles with systemic
antibiotics. The population of Propionibacterium
Differential diagnosis
acnes within follicles is markedly elevated in pa-
PD is usually a straightforward clinical diag- tients who apply local corticosteroids. Propionibac-
nosis (5). However, on differential diagnosis few terium acnes inflame follicles directly by producing
facial skin diseases should be excluded (Table 2). agents chemotactic for polymorphonuclear leuko-
Facial demodicosis (infestation with Demodexfol- cytes. Fusobacteria are often found in PD induced
liculorum) clinically resembles PD and should be by fluorinated corticosteroids. Besides these two
excluded, especially when anti-inflammatory ther- bacteria, in facial dermatoses induced by local
apies fail. Patients who are prone to acne or ro- corticosteroids one can find gram-negative bacte-
sacea may experience worsening while undergo- ria, staphylococci or sometimes even streptococ-
ing topical immunomodulating therapy (e.g., with ci. Preference is given to lipophilic tetracyclines
tacrolimus ointment). Haber syndrome, or familial like oxytetracycline, monocycline or doxycycline,
rosacea-like dermatosis with intraepidermal epi- 100-250 mg per day for 3-4 months, rarely longer.
theliomas, keratotic plaques and scars, is a rare To prevent poststeroid flare, oral tetracyclines are
genodermatosis that begins in childhood. Granu- contraindicated in children younger than 11 years.
lomatous periorificial dermatitis manifests most Acceptable treatment for children includes oral as
commonly in prepubertal children as yellow-brown well as topical erythromycin and topical metroni-
papules limited to the perioral, perinasal and peri- dazole. If there is no response to full dose of tet-
ocular regions. The condition is self-limiting and is racyclines, one may have to resort to isotretinoin.
not associated with systemic involvement. Quite low doses are effective; usually 5 mg as a
simple daily dose for about 3 months; even 2-3
Treatment mg/day may be helpful. Precautions must be tak-
The first step in therapeutic management en in women of childbearing potential. In less se-
should be discontinuation of all suspected topicals vere cases only, a neutral local therapy combined
which, however, usually leads to relapse of skin with anti-inflammatory agents can be used, mostly
lesion. One should insist on abandonment of all local erythromycin and metronidazole, neomycin,
cosmetics, soaps, detergents, moisturizers, abra- clindamycin and oxytetracycline administered in a
sives, adstrigents, day or night creams, skin con- nongreasy base (e.g., gel, lotion or cream). They
ditioners, etc. Washing with mild water only, using have both moisturizing and antibiotic effects. The
fingers is suggested by some authors. However, response of PD to metronidazole is the result of
this “null (zero) therapy” is hard for many patients, the drug’s anti-inflammatory and immunosuppres-
so local neutral treatment such as neutral local sive effects rather than the direct antimicrobial
creams and compresses (chamomile tea, physi- action (12). Topical antiacne medications such as
ologic solution, etc.) have to be used. The duration adapalene and azelaic acid have been used (13)
of treatment is shorter with men because they give in open studies. Ointments should be avoided.
up the idea of ever being cured sooner than the In severe cases of PD, local immunomodulatory
women do. Sometimes the physician must provide creams such as tacrolimus and pimecrolimus can
a great deal of psychological support during office be used (14,15).
visits. Some of the patients develop corticosteroid Topical antipruritics containing no corticoste-
dependence and therefore need medical help in- roids, such as liquid pramoxine hydrochloride, of-
cluding psychological support to break the habit fer excellent symptomatic relief. The response to
(8). local treatment with sulfur, resorcin and ichthyol
The patients have to be told that exacerbation was very unsatisfactory.
is to be expected and that it may take many weeks
to purify, and that the disease slowly regresses Conclusion
when exogenous factors are eliminated. Some PD has become a quite common facial derma-
investigators treat rebound phenomenon patients titis nowadays because of the inappropriate use of
with hydrocortisone, because hydrocortisone cuts topical steroids on the face. Various environmen-
down the violence of the rebound reaction, while tal sensitivities have been reported. The link to
rosacea is not certain but the two disorders occur 8. Wells K, Brodell RT. Topical corticosteroid “ad-
in the same population and both respond to the diction”: a cause of perioral dermatitis. Post-
same drugs. grad Med 1993;93:225-30.
9. Sneddon IB. The treatment of steroid-induced
References rosacea and perioral dermatitis. Dermatolo-
1. Frumess GM, Lewis HM. Light-sensitive se- gica 1976;152:231-7.
borrheid. Arch Dermatol 1957;75:245-8. 10. Cochron RE, Thompson J. Perioral dermatitis:
2. Monders SM, Lucky AW. Perioral dermatitis in a reappraisal. Clin Exp Dermatol 1979; 4:75-
childhood. J Am Acad Dermatol 1992; 27:688- 80.
92. 11. Bikowski JB. Topical therapy for perioral der-
3. Sneddon I. Perioral dermatitis. Br J Derm matitis. Cutis 1983; 31:678-82.
1972;87:430. 12. Veien NK, Munkvad JM, Nielsen AO, et al. To-
4. Kammler H. Perioral dermatitis. E medicine. pical metronidazole in the treatment of perioral
(last updated february 2005) http://www.eme- dermatitis. J Am Acad Dermatol 1991; 87:425-
dicine.com/derm/topic321.htm. 29.
5. Ljubojević S, Basta-Juzbašić A, Lipozenčić J. 13. Webster GF. Rosacea and Related Disorders.
Steroid dermatitis resembling rosacea-etio- In: Bolognia JL, Jorizzo JL, Rappini RP, eds.
pathogenesis and treatment. JEADV 2002; Dermatology. Edinburg:Mosby;2003. pp. 545-
16:121-6. 52.
6. Ackerman AB: Histologic Diagnosis of In- 14. Antille C, Saurat JH, Lubbe J. Induction of ro-
flammatory Skin Diseases. Philadelphia: saceiform dermatitis during treatment of facial
Lea&Febiger;1978. pp.803-5 inflammatory dermatoses with tacrolimus oint-
7. Dirschka T, Tronnier H, Fölster-Holst R. Epit- ment. Arch Dermatol 2004;140:457-60.
helial barrier function and atopic diathesis in 15. Goldman D. Tacrolimus ointment for the treat-
rosacea and perioral dermatitis. Br J Dermatol ment of steroid induced rosacea: a preliminary
2004;150:1136-41. report. J Am Dermatol 2001;44:995-8.